May, Patrick C

Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor. [electronic resource] - The Journal of neuroscience : the official journal of the Society for Neuroscience Nov 2011 - 16507-16 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1529-2401

10.1523/JNEUROSCI.3647-11.2011 doi


Adult
Alzheimer Disease--cerebrospinal fluid
Amyloid Precursor Protein Secretases--analysis
Amyloid beta-Peptides--cerebrospinal fluid
Amyloid beta-Protein Precursor--cerebrospinal fluid
Analysis of Variance
Animals
Aspartic Acid Endopeptidases--analysis
Cells, Cultured
Cerebral Cortex--cytology
Crystallography--methods
Disease Models, Animal
Dogs
Dose-Response Relationship, Drug
Embryo, Mammalian
Enzyme Inhibitors--blood
Enzyme-Linked Immunosorbent Assay--methods
Female
Humans
Male
Mice
Mice, Transgenic
Middle Aged
Models, Chemical
Mutation--genetics
Neurons--drug effects
Peptide Fragments--cerebrospinal fluid
Pyrimidines--pharmacology
Rats
Rats, Sprague-Dawley
Thiazines--pharmacology
Time Factors
Young Adult